Selling by month
Oct 2025 to Oct 2026. Each sale is counted once: under a disclosed plan, else to cover taxes, else no plan disclosed.
Disclosed planTo cover taxesOne dollar scale for every month; the tallest bar is labeled
Pattern
What the filings show, past 12 months. Nothing here rates or predicts.
- Sold in 5 of the 13 calendar months from Oct 2025 to Oct 2026: Nov 2025, Dec 2025, Feb 2026, Apr 2026 and Sep 2026.
- Largest single sale: $2.4M (67,115 shares) of Travere Therapeutics, Inc. on Nov 4, 2025. Filing
- Last sale before this period: Feb 11, 2025.
Roles from filings
Every company we track where this person has filed, newest filing first.
| Company | Title | First filing | Latest filing |
|---|---|---|---|
| Travere Therapeutics, Inc. (TVTX) | SVP, Chief Accounting Officer | Sep 23, 2021 | Sep 17, 2026 |
Recent filings
The last 5 days with transactions, newest first, one line per trade date. Each number links to an SEC filing.
- Sep 15, 2026, Travere Therapeutics, Inc.: sold 5,375 shares for $335K, under a disclosed plan; 5,375 shares acquired by exercising options. 1 filing: 1
- Apr 14, 2026, Travere Therapeutics, Inc.: sold 21,977 shares for $903K, under a disclosed plan; 15,250 shares acquired by exercising options. 1 filing: 1
- Feb 3, 2026, Travere Therapeutics, Inc.: sold 4,333 shares for $139K, to cover taxes. 1 filing: 1
- Jan 31, 2026, Travere Therapeutics, Inc.: 15,180 shares granted. 1 filing: 1
- Dec 24, 2025, Travere Therapeutics, Inc.: sold 7,402 shares for $296K, under a disclosed plan. 1 filing: 1
This page shows only what this person reported on SEC ownership filings. See the methodology. Spotted something wrong? Report an error.